Chrysa Mineo
Director/Board Member at CIDARA THERAPEUTICS, INC.
Net worth: - $ as of 30/04/2024
Chrysa Mineo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CIDARA THERAPEUTICS, INC. | Director/Board Member | 01/03/2018 | - |
| Independent Dir/Board Member | 01/03/2018 | - | |
San Diego French-American School
 San Diego French-American School Other Consumer ServicesConsumer Services San Diego French-American School is associated with a fund that was created to overcome negative crisis consequences, ensure long-term sustainability, and promote the integration of economies of the state participants. No other information about the American company's activities or achievements is given. | Director/Board Member | - | - |
San Diego Natural History Museum
 San Diego Natural History Museum Other Consumer ServicesConsumer Services San Diego Natural History Museum operates as a premier collections-based environmental education and natural history research resource. The company was founded in 1874 and is headquartered in San Diego, CA. | Director/Board Member | - | - |
| Scripps Institution of Oceanography | Corporate Officer/Principal | - | - |
Career history of Chrysa Mineo
Former positions of Chrysa Mineo
| Companies | Position | Start | End |
|---|---|---|---|
| RECEPTOS INC | Corporate Officer/Principal | 04/12/2009 | 01/01/2015 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/01/1997 | 01/01/2009 |
Alume Biosciences, Inc.
 Alume Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alume Biosciences, Inc. operates as an biotechnology company. It develops nerve- targeted pharmaceuticals for surgical and therapeutic use. The company was founded by Quyen Nguyen, Brett Berman, Chrysa Mineo, Mike Whitney, and Roger Tsien in 2017 and is headquartered in San Diego, CA. | Founder | 01/01/2017 | - |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Director/Board Member | - | - |
Baxter Biotech Group
 Baxter Biotech Group Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Baxter Biotech Group manufactures medical devices. The private company is based in Tokyo, Japan. | Sales & Marketing | - | - |
| ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Chrysa Mineo
| University of California, Davis | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Statistics
International
| United States | 14 |
| Japan | 2 |
Operational
| Corporate Officer/Principal | 6 |
| Director/Board Member | 4 |
| Sales & Marketing | 1 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 6 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| CIDARA THERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
| DNAX Research, Inc. | |
Baxter Biotech Group
Baxter Biotech Group Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Baxter Biotech Group manufactures medical devices. The private company is based in Tokyo, Japan. | Health Technology |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Health Technology |
San Diego Natural History Museum
San Diego Natural History Museum Other Consumer ServicesConsumer Services San Diego Natural History Museum operates as a premier collections-based environmental education and natural history research resource. The company was founded in 1874 and is headquartered in San Diego, CA. | Consumer Services |
San Diego French-American School
San Diego French-American School Other Consumer ServicesConsumer Services San Diego French-American School is associated with a fund that was created to overcome negative crisis consequences, ensure long-term sustainability, and promote the integration of economies of the state participants. No other information about the American company's activities or achievements is given. | Consumer Services |
Alume Biosciences, Inc.
Alume Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alume Biosciences, Inc. operates as an biotechnology company. It develops nerve- targeted pharmaceuticals for surgical and therapeutic use. The company was founded by Quyen Nguyen, Brett Berman, Chrysa Mineo, Mike Whitney, and Roger Tsien in 2017 and is headquartered in San Diego, CA. | Commercial Services |
- Stock Market
- Insiders
- Chrysa Mineo
- Experience